Drugs that inhibit estrogen receptor alpha (ERα) or which block the production of estrogens remain frontline interventions in the treatment and management of breast cancer at all stages. In this study, researchers found that molecular mechanism of action at estrogen receptor α of GW7604. GW7604 is a clinically relevant...